Santarus, Inc. (SNTS): Passive Hedge Fund Just Upped Its Stake By 149%

A market-moving update, Jacob Gottlieb’s Visium Asset Management purchased 2,294,704 shares of Santarus, Inc. (NASDAQ:SNTS) in a 13G filing with the Securities and Exchange Commission. Altogether, the position in Santarus, Inc.  is now valued at around 3,834,704, an increase of 149%.

Santarus, Inc. (NASDAQ:SNTS)

Looking at the entire picture, 13Gs indicate the intentions of passive hedge fund managers. These members of the smart money aren’t exposed to an equal level of popularity as their activist peers, but passive managers must be watched in a similar light.

To put it simply, it’s very beneficial for average investors to pay attention to Jacob Gottlieb’s latest investment into Santarus, Inc. (NASDAQ:SNTS).

Though It’s important to pay attention to many equity-based metrics, there’s one that is often overlooked: aggregate hedge fund sentiment.

Empirical studies have demonstrated that retail investors who follow specific hedge fund activity can outperform the S&P 500 by an average of 18 percentage points per year (see the details here).

Focusing in onSantarus, Inc. (NASDAQ:SNTS), our records indicate that 18 other hedge funds were long Santarus, Inc. (NASDAQ:SNTS) at the end of last quarter. In particular, Kevin Kotler’s Broadfin Capital, Steven Cohen’s SAC Capital Advisors, and Mark Kingdon’s Kingdon Capital, held shares of Santarus, Inc., which is some of the best company anyone can be in the same vicinity as.

Moreover, we should mention some other positions in Visium Asset Management’s equity portfolio, aside from Santarus, Inc..

As follows, they include MannKind Corporation (NASDAQ:MNKD), PDL BioPharma Inc. (NASDAQ:PDLI) and PDL BioPharma Inc. (NASDAQ:PDLI), and are listed below:

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
MannKind Corporation (NASDAQ:MNKD) 8 2 0
PDL BioPharma Inc. (NASDAQ:PDLI) 14 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 16 0 1

With that being said, we’ll keep you updated about the smart money’s investment plays surrounding
Santarus, Inc. (NASDAQ:SNTS).

Click here to learn why you should track hedge funds